|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lee YC, Chiang TH, Chou CK, Tu YK, Liao
WC, Wu MS and Graham DY: Association between helicobacter pylori
eradication and gastric cancer incidence: A systematic review and
meta-analysis. Gastroenterology. 150:1113–1124.e5. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
van den Brandt PA: The impact of a healthy
lifestyle on the risk of esophageal and gastric cancer subtypes.
Eur J Epidemiol. 37:931–945. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ohashi M, Kanai F, Ueno H, Tanaka T,
Tateishi K, Kawakami T, Koike Y, Ikenoue T, Shiratori Y, Hamada H
and Omata M: Adenovirus mediated p53 tumour suppressor gene therapy
for human gastric cancer cells in vitro and in vivo. Gut.
44:366–371. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Oliveira C, Pinheiro H, Figueiredo J,
Seruca R and Carneiro F: Familial gastric cancer: Genetic
susceptibility, pathology, and implications for management. Lancet
Oncol. 16:e60–e70. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li
G, Xiong W and Zeng Z: Intestinal flora and disease mutually shape
the regional immune system in the intestinal tract. Front Immunol.
11(575)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Perez-Lopez A, Behnsen J, Nuccio SP and
Raffatellu M: Mucosal immunity to pathogenic intestinal bacteria.
Nat Rev Immunol. 16:135–148. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hariton E and Locascio JJ: Randomised
controlled trials-the gold standard for effectiveness research:
Study design: Randomised controlled trials. Bjog.
125(1716)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Birney E: Mendelian randomization. Cold
Spring Harb Perspect Med. 12(a041302)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kuper H, Nicholson A, Kivimaki M,
Aitsi-Selmi A, Cavalleri G, Deanfield JE, Heuschmann P, Jouven X,
Malyutina S, Mayosi BM, et al: Evaluating the causal relevance of
diverse risk markers: Horizontal systematic review. BMJ.
339(b4265)2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Graham SE, Clarke SL, Wu KH, Kanoni S,
Zajac GJM, Ramdas S, Surakka I, Ntalla I, Vedantam S, Winkler TW,
et al: The power of genetic diversity in genome-wide association
studies of lipids. Nature. 600:675–679. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Boehm FJ and Zhou X: Statistical methods
for mendelian randomization in genome-wide association studies: A
review. Comput Struct Biotechnol J. 20:2338–2351. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Burgess S and Thompson SG: Interpreting
findings from mendelian randomization using the MR-Egger method.
Eur J Epidemiol. 32:377–389. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bowden J, Davey Smith G, Haycock PC and
Burgess S: Consistent estimation in mendelian randomization with
some invalid instruments using a weighted median estimator. Genet
Epidemiol. 40:304–314. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin L, Luo P, Yang M, Wang J, Hou W and Xu
P: Causal relationship between osteoporosis and osteoarthritis: A
two-sample mendelian randomized study. Front Endocrinol (Lausanne).
13(1011246)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim S, Covington A and Pamer EG: The
intestinal microbiota: Antibiotics, colonization resistance, and
enteric pathogens. Immunol Rev. 279:90–105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pamer EG: Resurrecting the intestinal
microbiota to combat antibiotic-resistant pathogens. Science.
352:535–538. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Trompette A, Gollwitzer ES, Yadava K,
Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod
LP, Harris NL and Marsland BJ: Gut microbiota metabolism of dietary
fiber influences allergic airway disease and hematopoiesis. Nat
Med. 20:159–166. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao C, Bao L, Zhao Y, Wu K, Qiu M, Feng
L, Zhang N, Hu X and Fu Y: A fiber-enriched diet alleviates
staphylococcus aureus-induced mastitis by activating the
HDAC3-mediated antimicrobial program in macrophages via butyrate
production in mice. PLoS Pathog. 19(e1011108)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hu X, Guo J, Zhao C, Jiang P, Maimai T,
Yanyi L, Cao Y, Fu Y and Zhang N: The gut microbiota contributes to
the development of staphylococcus aureus-induced mastitis in mice.
ISME J. 14:1897–1910. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Coker OO, Dai Z, Nie Y, Zhao G, Cao L,
Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY and Yu J: Mucosal
microbiome dysbiosis in gastric carcinogenesis. Gut. 67:1024–1032.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Aviles-Jimenez F, Vazquez-Jimenez F,
Medrano-Guzman R, Mantilla A and Torres J: Stomach microbiota
composition varies between patients with non-atrophic gastritis and
patients with intestinal type of gastric cancer. Sci Rep.
4(4202)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ferreira RM, Pereira-Marques J,
Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC and Figueiredo C:
Gastric microbial community profiling reveals a dysbiotic
cancer-associated microbiota. Gut. 67:226–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dicksved J, Lindberg M, Rosenquist M,
Enroth H, Jansson JK and Engstrand L: Molecular characterization of
the stomach microbiota in patients with gastric cancer and in
controls. J Med Microbiol. 58:509–516. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Demiryas S, Caliskan R, Saribas S, Akkus
S, Gareayaghi N, Kirmusaoglu S, Kepil N, Dinc H, Dag H, Dagdeviren
E, et al: The association between cagL and cagA, vacAs-m, babA
genes in patients with gastric cancer, duodenal ulcer, and
non-ulcer dyspepsia related to helicobacter pylori. Acta
Gastroenterol Belg. 83:385–392. 2020.PubMed/NCBI
|
|
26
|
Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng
Y, Liu F, Yan C, Li L and Ling Z: Alterations of gastric mucosal
microbiota across different stomach microhabitats in a cohort of
276 patients with gastric cancer. EBioMedicine. 40:336–348.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gunathilake MN, Lee J, Choi IJ, Kim YI,
Ahn Y, Park C and Kim J: Association between the relative abundance
of gastric microbiota and the risk of gastric cancer: A
case-control study. Sci Rep. 9(13589)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Brawner KM, Morrow CD and Smith PD:
Gastric microbiome and gastric cancer. Cancer J. 20:211–216.
2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Meng C, Bai C, Brown TD, Hood LE and Tian
Q: Human gut microbiota and gastrointestinal cancer. Genomics
Proteomics Bioinformatics. 16:33–49. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lawrie CH, Marafioti T, Hatton CS,
Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K
and Banham AH: Cancer-associated carbohydrate identification in
hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer.
118:3161–3166. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dai D, Yang Y, Yu J, Dang T, Qin W, Teng
L, Ye J and Jiang H: Interactions between gastric microbiota and
metabolites in gastric cancer. Cell Death Dis.
12(1104)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rooks MG and Garrett WS: Gut microbiota,
metabolites and host immunity. Nat Rev Immunol. 16:341–352.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Smith PM, Howitt MR, Panikov N, Michaud M,
Gallini CA, Bohlooly-Y M, Glickman JN and Garrett WS: The microbial
metabolites, short-chain fatty acids, regulate colonic treg cell
homeostasis. Science. 341:569–573. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J,
Zhu H, Dai Z, Wang D and Tang D: The roles of microbial products in
the development of colorectal cancer: A review. Bioengineered.
12:720–735. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Byndloss MX, Olsan EE, Rivera-Chávez F,
Tiffany CR, Cevallos SA, Lokken KL, Torres TP, Byndloss AJ, Faber
F, Gao Y, et al: Microbiota-activated PPAR-γ signaling inhibits
dysbiotic enterobacteriaceae expansion. Science. 357:570–575.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dodd D, Spitzer MH, Van Treuren W, Merrill
BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP,
Fischbach MA and Sonnenburg JL: A gut bacterial pathway metabolizes
aromatic amino acids into nine circulating metabolites. Nature.
551:648–652. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Crost EH, Coletto E, Bell A and Juge N:
Ruminococcus gnavus: Friend or foe for human health. FEMS Microbiol
Rev. 47(fuad014)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
La Reau AJ and Suen G: The Ruminococci:
Key symbionts of the gut ecosystem. J Microbiol. 56:199–208.
2018.PubMed/NCBI View Article : Google Scholar
|
